Pediatric Cardiology News

The European Society of Cardiology released a new guideline on adult congenital heart disease emphasizing lifelong follow-up and endorsing catheter-based interventions when possible.

Children with heterozygous familial hypercholesterolemia who received monthly injections of evolocumab had greater reductions in LDL and other lipid variables at 24 weeks compared with placebo, according to results of the HAUSER-RCT trial.

Adults who received radiation therapy during childhood for abdominal and pelvic cancers appeared more likely than the general population to experience body composition abnormalities and worse cardiometabolic outcomes, study results showed.

Corticosteroids with standard treatment for patients with Kawasaki disease reduced the risk for coronary artery abnormalities and treatment failure, researchers found.

Efficacy of hydroxychloroquine to reduce recurrence rate of congenital heart block.

Dexamethasone vs. placebo to reduce major complications and mortality during cardiac surgery in infants.

Interstage home monitoring programs for babies who underwent surgery due to heart defects reduced infant mortality by approximately 40%, according to a scientific statement from the American Heart Association.

Healio and Cardiology Today have compiled a list of the most-read articles of July 2020.

Among adults with congenital heart disease hospitalized for HF, mortality risk remained high for up to 4 years after hospital discharge, according to a study published in Circulation: Heart Failure.

More than half of children aged 12 to 15 years do not have healthy cardiorespiratory function, according to a scientific statement released by the American Heart Association.